Editorial: Prevalence of Suspected Metabolic Dysfunction-Associated Liver Disease in Adolescents in the United States Using Updated Diagnostic Criteria-Authors' Reply
- PMID: 40091192
- DOI: 10.1111/apt.70092
Editorial: Prevalence of Suspected Metabolic Dysfunction-Associated Liver Disease in Adolescents in the United States Using Updated Diagnostic Criteria-Authors' Reply
References
-
- J. Bonn and S. Xanthakos, “Editorial: Prevalence of Suspected Metabolic Dysfunction Associated Liver Disease in Adolescents in the United States Using Updated Diagnostic Criteria,” Alimentary Pharmacology & Therapeutics 61, no. 9 (2025): 1555–1556.
-
- S. L. Noon, L. F. Chun, T. B. N. Lam, N. Q. N. Thai, W. Dunn, and J. B. Schwimmer, “Prevalence and Predictors of Suspected Metabolic Dysfunction‐Associated Steatotic Liver Disease in Adolescents in the United States,” Alimentary Pharmacology & Therapeutics 61, no. 9 (2025): 1479–1488.
-
- A. Hildreth, W. L. Shapiro, B. M. Lowenthal, A. Goyal, and J. B. Schwimmer, “Distinguishing Autoimmune Hepatitis From Steatohepatitis in Adolescents With Obesity and Positive Screening Alanine Aminotransferase,” JPGN Reports 4, no. 2 (2023): 292, https://doi.org/10.1097/PG9.0000000000000292.
-
- J. B. Schwimmer, C. Behling, R. Newbury, et al., “Histopathology of Pediatric Nonalcoholic Fatty Liver Disease,” Hepatology 42, no. 3 (2005): 641–649, https://doi.org/10.1002/hep.20842.
-
- N. P. Goyal, S. Xanthakos, and J. B. Schwimmer, “Metabolic Dysfunction‐Associated Steatotic Liver Disease in Children,” Gut 74, no. 4 (2025): 669–677, https://doi.org/10.1136/gutjnl‐2023‐331090.
Publication types
LinkOut - more resources
Full Text Sources